(EIDX) |
| 0 (0%) 02-22 04:42 |
| Open: | |
| High: | |
| Low: | |
| Volume: | 0 |
| Market Cap: | 0(M) |
| PE Ratio: | 0 |
| Exchange: | |
| Industry: | |
| Sector: |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 132.54 |
| Resistance 1: | 126.31 |
| Pivot price: | 123.73 |
| Support 1: | 116.24 |
| Support 2: | 96.71 |
| 52w High: | |
| 52w Low: |
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 12 Aug 2019
Little over year after IPO, biotech's majority owner wants to buy it all - The Business Journals
Thu, 27 Jun 2019
How Neil Kumar's new biotech model capped a $350 million IPO - The Business Journals
Sat, 04 May 2019
Eidos Therapeutics : RM LAW Announces an Investigation of Eidos Therapeutics, Inc. - marketscreener.com
Fri, 04 Jan 2019
INVESTIGATION ALERT: The Schall Law Firm Announces It is Investigating Claims against Eidos Therapeutics, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm - marketscreener.com
Sun, 22 Feb 2026
Sun, 22 Feb 2026
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
